Asensus Surgical

ASXC45

Penny Stock

$0.35arrow_drop_up0.60%$0.00

Penny Stock

ASXC45

$0.35

arrow_drop_up0.60%$0.00

Penny Stock

Performance History

Key Stats
Open	$0.35
Prev. Close	$0.34
EPS	-0.31
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$94.92M
PE Ratio	-

	LOW	HIGH
Day Range	0.35	0.35
52 Week Range	0.16	0.40

Ratios







EPS	-0.31

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Asensus Surgical (ASXC)

Asensus Surgical, Inc. (ASXC) is a medical technology company that specializes in the development and commercialization of surgical robotic systems. The company focuses on the advancement of minimally invasive surgery through its innovative technology platform. Asensus Surgical's flagship product is the Senhance Surgical System, which combines robotics and artificial intelligence to assist surgeons during complex procedures. This system provides enhanced visualization, precision, and control, resulting in improved patient outcomes.

The ASXC stock has shown a significant increase in value over the years. The price history of Asensus Surgical, Inc. reveals a steady upward trend, with occasional fluctuations in response to market conditions and company news. Investors have recognized the potential of Asensus Surgical's technology and its application in the healthcare industry.

Asensus Surgical's stock quote provides real-time information on the current trading price of ASXC. Investors can track the stock's performance and make informed decisions based on market trends and analysis. The ASXC stock news keeps investors updated on the latest developments, such as product launches, clinical trials, partnerships, and financial results. Staying informed about these news can help investors assess the company's growth prospects.

Analyzing Asensus Surgical, Inc.'s stock is crucial for investors. ASXC stock analysis involves evaluating various factors such as financial performance, industry trends, competitive landscape, and market outlook. Detailed analysis helps investors understand the company's potential for future growth and the risks associated with investing in ASXC.

Smart analysis tools are available to assist investors in making data-driven decisions. Asensus Surgical, Inc. offers smart analysis tools that provide comprehensive insights into the company's performance, market trends, and industry comparisons. These tools use advanced algorithms and data analytics to generate accurate and up-to-date information for investors to analyze and interpret.

When conducting a smart analysis of Asensus Surgical, Inc., investors should consider factors such as the company's financial stability, revenue growth, market share, and competitive advantages. Understanding the key drivers behind ASXC's success can help investors determine whether the stock is a good investment option.

Asensus Surgical, Inc.'s market capitalization refers to the total value of the company's outstanding shares. It is calculated by multiplying the current stock price by the number of shares outstanding. ASXC market cap provides an indication of the company's size and valuation in the market. Investors often consider market cap when assessing the risk and potential return of investing in a particular stock.

The PEG ratio is a useful tool for investors to evaluate a company's valuation relative to its earnings growth. Asensus Surgical, Inc.'s PEG ratio can be calculated by dividing the price-earnings (P/E) ratio by the expected earnings growth rate. A low PEG ratio indicates that the stock may be undervalued relative to its earnings potential. Investors can compare ASXC's PEG ratio with that of its industry peers to assess its relative valuation.

Comparing Asensus Surgical, Inc.'s performance with its industry peers can provide valuable insights for investors. ASXC vs industry analysis involves evaluating key financial metrics such as revenue growth, profitability, and market share. Understanding how Asensus Surgical compares to its competitors can help investors assess its strengths, weaknesses, and growth potential within the industry.

The 52-week range of Asensus Surgical, Inc. represents the highest and lowest prices at which the stock has traded over the past year. This range provides investors with a historical perspective on ASXC's stock performance and volatility. It helps investors gauge the stock's potential for growth and identify buying or selling opportunities based on market trends.

The day range of Asensus Surgical, Inc. refers to the highest and lowest prices at which the stock has traded during a specific trading day. Tracking the day range allows investors to monitor intraday price fluctuations and assess the stock's trading activity. High trading volume within the day range may indicate increased investor interest in ASXC.

Investing in Asensus Surgical, Inc., ASXC can be a strategic decision for investors looking to capitalize on the advancements in surgical robotics and minimally invasive surgery. The company's innovative Senhance Surgical System offers enhanced precision, control, and visualization to surgeons, resulting in improved patient outcomes. Asensus Surgical's technology has the potential to revolutionize the field of surgery and address the growing demand for less invasive procedures.

The ASXC stock has demonstrated a positive trajectory, with consistent growth and occasional fluctuations in response to market conditions and company news. Investors recognize the potential of Asensus Surgical's technology and its ability to reshape the healthcare industry.

Staying informed about Asensus Surgical, Inc.'s latest developments is crucial for investors. The ASXC stock news provides real-time updates on product launches, partnerships, clinical trials, and financial results. These news can influence the stock's performance and help investors make informed decisions based on the company's progress.

Analyzing Asensus Surgical, Inc.'s stock involves evaluating various factors such as financial performance, industry trends, and competitive landscape. Investors can utilize ASXC stock analysis tools to gain insights into the company's growth prospects and assess its potential for investment.

Smart analysis tools offered by Asensus Surgical, Inc. provide advanced algorithms and data analytics to support investors in decision making. These tools enable investors to analyze market trends, compare industry peers, and assess the company's financial stability and future growth potential.

Considering Asensus Surgical, Inc.'s market capitalization is important for investors. The company's market cap reflects its size, valuation, and prominence in the market. ASXC market cap can be used to gauge investor sentiment and assess the stock's potential for growth and return on investment.

The PEG ratio is a valuable metric for investors to evaluate a stock's valuation relative to its expected earnings growth. Calculating Asensus Surgical, Inc.'s PEG ratio involves dividing the P/E ratio by the expected earnings growth rate. Investors can compare ASXC's PEG ratio with industry peers to determine its relative valuation and investment potential.

Analyzing Asensus Surgical, Inc.'s performance in comparison to industry peers helps investors understand its competitive position. ASXC vs industry analysis involves evaluating key financial indicators such as revenue growth, profitability, and market share. This analysis enables investors to assess Asensus Surgical's strengths, weaknesses, and growth opportunities within the industry.

The 52-week range provides insight into Asensus Surgical, Inc.'s stock performance over the past year. Understanding the highest and lowest prices at which the stock has traded can help investors gauge its volatility and potential for growth. Tracking the 52-week range assists investors in identifying buying or selling opportunities based on market trends.

Monitoring the day range of Asensus Surgical, Inc. allows investors to track intraday price fluctuations. The highest and lowest prices at which the stock trades during a specific trading day provide insights into investor sentiment and trading activity. High trading volume within the day range may indicate increased investor interest and influence the stock's performance.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Anthony Fernando
Headquarters: Durham
Employees: 183
Exchange: NYSE

Keep an eye on Asensus Surgical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Asensus Surgical's (ASXC) price per share?

The current price per share for Asensus Surgical (ASXC) is $0.35. The stock has seen a price change of $0 recently, indicating a 0.6% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Asensus Surgical (ASXC)?

For Asensus Surgical (ASXC), the 52-week high is $0.4, which is 14.29% from the current price. The 52-week low is $0.17, the current price is 107.1% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Asensus Surgical (ASXC) a growth stock?

Asensus Surgical (ASXC) has shown an average price growth of 0.41% over the past three years. It has received a score of 13 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Asensus Surgical as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Asensus Surgical (ASXC) stock price performance year to date (YTD)?

As of the latest data, Asensus Surgical (ASXC) has a year-to-date price change of 9.92%. Over the past month, the stock has experienced a price change of 1.24%. Over the last three months, the change has been 7.96%. Over the past six months, the figure is 21.53%.

help

Is Asensus Surgical (ASXC) a profitable company?

Asensus Surgical (ASXC) has a net income of -$78.43M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -808.43% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $8.58M, with a revenue growth rate of 21.02%, providing insight into the company's sales performance and growth. Operating income is noted at -$78.13M. Furthermore, the EBITDA is -$67.47M.

help

What is the market capitalization of Asensus Surgical (ASXC)?

Asensus Surgical (ASXC) has a market capitalization of $94.92M. The average daily trading volume is 4.03M, indicating the stock's liquidity and investor engagement.